ErbB4, a member of the epidermal growth factor (EGF) receptor family that can be activated by heregulin ␤1 and heparin binding (HB)-EGF, is expressed as alternatively spliced isoforms characterized by variant extracellular juxtamembrane (JM) and intracellular cytoplasmic (CYT) domains. ErbB4 plays a critical role in cardiac and neural development. We demonstrated that ErbB4 is expressed in the ureteric buds and developing tubules of embryonic rat kidney and in collecting ducts in adult. The predominant isoforms expressed in kidney are JM-a and CYT-2. In ErbB4-transfected MDCK II cells, basal cell proliferation and hepatocyte growth factor (HGF)-induced tubule formation were decreased by all four isoforms. Only JM-a/CYT-2 cells formed tubules upon HB-EGF stimulation. ErbB4 was activated by both HRG-␤1 and
INTRODUCTION
ErbB4, a type I transmembrane receptor tyrosine kinase, belongs to the EGF receptor family, which consists of four receptors, ErbB1 (EGFR or HER1), ErbB2 (Neu, HER2), ErbB3 (HER3), and ErbB4 (HER4; Olayioye et al., 2000) . ErbB receptors are involved in the regulation of cellular proliferation, differentiation, survival, and migration in response to activation by their ligands (Yarden and Sliwkowski, 2001) . The binding of receptor-specific ligands to the extracellular domains of the receptors results in the formation of homoand hetero-dimeric receptor complexes and subsequent activation of intracellular signaling pathways (Olayioye et al., 2000) . More than a dozen ligands have been found to interact with the ErbB family receptors (Riese and Stern, 1998) . Among these, ErbB4 ligands belong to two groups: the neuregulins (NRG1-4), also termed heregulins (HRG), and some members of the EGF family (betacellulin, epiregulin, and heparin-binding EGF-like [HB-EGF] growth factor) that were originally discovered as activators of ErbB1. NRG1 and NRG2 have a number of splice variants and also bind to ErbB3, whereas NRG3 and NRG4 interact with low affinity only with ErbB4 (Olayioye et al., 2000) . In most assays, NRG1, which contains a ␤-type (HRG-␤1) EGF-like domain, has been found to be 10 -100 times more potent than NRG2 with its ␣-type EGF-like domain (Beerli and Hynes, 1996; Riese et al., 1996; Elenius et al., 1997b; Falls, 2003) . Based on these observations, HRG-␤1 has been routinely utilized to stimulate ErbB4 activation.
ErbB4 is expressed as alternatively spliced isoforms that are characterized by variant extracellular juxtamembrane (JM) domains and intracellular cytoplasmic (CYT) domains. The JM domain of type a (JM-a) includes 23 amino acids that confer a proteinase cleavage site that is missing from the alternative 13 amino acids in the JM domain of type b (JM-b; Elenius et al., 1997b; Gilmour et al., 2001) . Two additional JM splice variants (JM-c and JM-d) have recently been identified with isoforms lacking or including, respectively, both JM-a and JM-b sequences (Gilbertson et al., 2001 ; Figure 1 ). Both JM-a and JM-d isoforms can be cleaved by ADAM 17, a member of the ADAM (a disintegrin and metalloprotease) family, also known as the tumor necrosis factor alpha-converting enzyme (TACE), in response to binding of ligands to ErbB4 (Zhou and Carpenter, 2000; Cheng et al., 2003) or activation of protein kinase C (Vecchi et al., 1996; Rio et al., 2000) . ErbB4 proteolytic cleavage releases a 120-kDa ectodomain fragment into the extracellular milieu and generates a membrane-associated 80-kDa fragment that can be degraded by proteasome activity after polyubiquitination (Vecchi and Carpenter, 1997) or can be further cleaved by ␥-secretase, which releases the intracellular domain (ICD) from the membrane and allows nuclear translocation (Ni et al., 2001; Lee et al., 2002) . Recent studies have shown that this ICD fragment can serve as a chaperone to facilitate the nuclear entry of the transcription factors STAT5a (56) and Yes-associated protein (YAP; Komuro et al., 2003; Omerovic et al., 2004) .
The CYT isoforms differ by containing (CYT-1) or not containing (CYT-2) a sequence of 16 amino acids within their cytoplasmic tails (Elenius et al., 1999) . These 16 amino acids This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E07-03-0223) on August 29, 2007. (SEIGHSPPPAYTPMSG) can serve as a binding site for the phosphatidylinositol 3-OH kinase (PI3K) SH2-domain (YTPM) and putatively for WW-domain containing signaling molecules (PY motif, PPXY, where X stands for any amino acid; Carpenter, 2003; Komuro et al., 2003;  Figure 1 ). Previous studies have reported differential coupling and activation of PI3K signaling between these two cytoplasmic variants (Kainulainen et al., 2000) .
In vivo, ErbB4 isoforms are expressed in a tissue-specific distribution. For example, ErbB4 JM-b is expressed mainly in the heart and ErbB4 JM-a mainly in kidney, whereas both juxtamembrane isoforms are expressed in various neural tissues (Elenius et al., 1997a) . On the other hand, heart expresses predominantly ErbB4 CYT-1; neural tissues and kidney predominantly ErbB4 CYT-2 (Elenius et al., 1999) . The tissue-specific expression of ErbB4 isoforms suggests that a level of specificity in isoform-specific function might exist.
The function of ErbB4 appears to vary depending on its context. ErbB4 has been shown to have an important role in cardiac and neural development. ErbB4 knockout mice died at midembryogenesis (embryonic day [E] 10.5) before the inception of nephrogenesis, due to impaired cardiac muscle differentiation and defects in pathfinding by cranial neural crest cells and in the migration of cerebellar granule cells along radial glial fibers (Gassmann et al., 1995) . Therefore, its role in renal development could not be assessed. We previously found that the ErbB4 ligands, HRG-␤1 (Harris, unpublished data) and HB-EGF, were expressed in the ureteric bud as early as E14.5, and there was persistent expression in structures arising from the ureteric bud throughout embryogenesis (Sakai et al., 1997) , which raised questions concerning the pattern of ErbB4 expression and possible functions in renal development and epithelial function. Furthermore, because PI3K signaling has been shown to have important roles in mediating cell survival and proliferation and ureteric bud growth in vitro (Grant et al., 2002; Brader and Eccles, 2004; Pozzi et al., 2006) , we initially hypothesized that the ErbB4 variant containing the PI3K binding site (CYT-1) might serve as a mediator of epithelial tubulogenesis. However, in the present study, we demonstrate that in both developing and adult kidney, the predominant ErbB4 isoforms expressed was CYT-2, which does not contain the PI3K-binding site. We found that in Madin-Darby canine kidney (MDCK) II cells, transfection of all ErbB4 isoforms inhibited basal proliferation, whereas cell adhesion and migration were differentially regulated. HGF-induced tubulogenesis was also inhibited by the expression of ErbB4 isoforms, but unexpectedly, CYT-2, the ErbB4 isoform without PI3K-binding site, induced tubulogenesis upon HB-EGF treatment, which correlated with selective HB-EGF-mediated receptor phosphorylation and nuclear translocation of this isoform.
MATERIALS AND METHODS

Cell Culture and Transfection
MDCK II cells were cultured at 37°C in a humidified air atmosphere with 5% CO 2. DMEM/F12 (Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine serum, streptomycin (100 g/ml), and penicillin (100 U/ml), was used as growth medium. The medium used for passage of the transfected cell lines was supplemented with 1 mg/ml G418 (Research Products International, Mount Prospect, IL).
The expression constructs encoding full-length human ErbB4 cloned in the pcDNA3.1 were kindly provided by Dr. Klaus Elenius (Department of Oncology, Turku University, Turku, Finland) and were sequenced after reamplification. To develop cells stably expressing human ErbB4 isoforms, MDCK II cells were transfected with pcDNA3.1 containing human ErbB4 isoform cDNAs, using Effectene Transfection Reagent (QIAGEN, Chatsworth, CA) according to the manufacturer's instruction. Stable transfectants were generated after selection with 1 mg/ml G418 for 3 to 4 wk. Positive clones were confirmed by immunoblotting with anti-ErbB4 antibody as described below, and two independent clones were studied for each construct.
Antibodies and Reagents
Recombinant human NRG-1-␤1/HRG-␤1 EGF domain was purchased from R&D Systems (Minneapolis, MN). Recombinant human HGF was from Chemicon International (Temecula, CA). HB-EGF, leptomycin B (LMB), and phorbol 13-myristate 12-acetate (PMA) were from Sigma-Aldrich (St. Louis, MO). Anti-ErbB4 (c-18), anti-phospho-ERK1/2 (42/44), and anti-phosphotyrosine (PY99) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-ErbB4 antibodies (Ab-2) were from Neomarkers (Fremont, CA). Both ErbB4 antibodies (c-18 and Ab2) were raised against ErbB4 c-terminus and can recognize all splice variants of ErbB4. Anti-phospho-ErbB4 tyr1284 , anti-phospho-Akt Ser473 , and anti-phospho-STAT3
Tyr705 were from Cell Signaling Technology (Beverly, MA). Rat tail collagen, type 1, was from BD Biosciences (San Jose, CA) and TO-PRO-3 iodide from Molecular Probes (Invitrogen).
Unless otherwise noted, antibodies were used at 1:200 for immunostaining and 1:1000 for immunoprecipitation and Western blot.
Immunohistochemistry
Immunohistochemistry was performed as previously described (Zhang et al., 2004) .
Real-Time PCR
Total RNA was isolated from embryonic or adult Sprague Dawley (SD) rat kidneys by the TRIzol reagent (Invitrogen) and was subsequently reversetranscribed to cDNA with Superscript II enzyme according to the manufacturer's instructions using random oligonucleotide primers (GIBCO-BRL, Rockville, MD).
Real-time PCR analysis of cDNA samples was performed with specific primers and fluorescent probes designed using the Beacon Designer 2 and synthesized by Sigma-Genosys (Table 1) . Each probe was double-labeled with the fluorescent reporter dye (6FAM) linked to the 5Ј-end of the probe and the black hole quencher dye (BHQ1) attached to the 3Ј-end. Quantitative PCR was performed in 96-well reaction plates using iCycler iQ Real Time PCR System (Bio-Rad, Richmond, CA). The reaction mixture contained an amount of cDNA corresponding to 200 ng of reverse-transcribed total RNA (20 ng for ubiquitin), 400-nm sense and antisense primers, and 200-nm probe in a final volume of 25 l using the TaqMan PCR mix (Applied Biosystems, Foster City, CA). Cycle parameters were 95°C ϫ 15 min and then 40 cycles of 94°C for 15 s 
Immunoblot Analysis
For cell culture, cells were prepared as follows: 1) for detection of the ErbB4 receptor expression levels, cells in exponential growth phase were trypsinized and 1 ϫ 10 6 cells were plated on 10-cm tissue culture dishes for 18 h before harvesting; 2) For detection of the level of tyrosine phosphorylated ErbB4 receptors, cells were grown to 80% confluence and starved overnight in serum-free DMEM/F12 containing 0.1% bovine serum albumin (BSA). After stimulation with 50 ng/ml HRG-␤1 or HB-EGF for 10 min at 37°C, cells were washed three times with ice-cold Ca 2ϩ -and Mg 2ϩ -free phosphate-buffered saline (PBS) and lysed with ice-cold TGH buffer (1% Triton X-100, 10% glycerol, 20 mM HEPES, pH 7.2, 100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml aprotinin, and 1 mM Na 3 VO 4 ). The lysates were incubated for 20 min on ice with intermittent vortexing. Insoluble material was removed by centrifugation (14,000 ϫ g, 15 min) at 4°C, and the supernatant was collected. Protein concentrations were assayed by the method of Bradford using BSA as the standard. For immunoprecipitation, ϳ1 g of ErbB4 antibody (c-18) or PY99 antibody was incubated (2 h at 4°C) with 500 g of cellular protein followed by overnight incubation with protein G-agarose (Invitrogen). Immune complexes were washed three times with TGH lysis buffer, resuspended in 2ϫ Laemmli buffer, and boiled for 5 min. 3) For testing the phosphorylation level of Akt, ERK1/2, and STAT3, cells were serum-starved for 24 h before seeding into collagen I solution (see below) at a concentration of 60,000 cells/100 l collagen I solution that contained 50 ng/ml HRG-␤1 or HB-EGF. Cells in collagen gel solution without growth factors were used as control. At different time points, 20 l of 6ϫ SDS sample buffer was added, and the cell-gel mixture was sonicated and boiled for 5 min. Equal volumes of each sample were loaded.
After SDS-PAGE, the proteins were transferred to polyvinylidene fluoride (PVDF) membranes for Western blotting. Immunoblots were blocked with TBST buffer (0.05% Tween 20, 150 mM NaCl, 50 mM Tris, pH 7.4) containing 5% nonfat milk powder (blocking buffer) at room temperature for 1 h. The membranes were probed overnight at 4°C with phospho-antibodies in TBST containing 3% BSA or total antibodies in blocking buffer, washed three times with TBST buffer, and incubated with peroxidase-conjugated secondary antibody. After thorough washing, the chemiluminescence reaction was performed, and the membranes were exposed to electrochemiluminescence (ECL) hyperfilm according to the manufacturer's instructions (Amersham Pharmacia Biotech, Piscataway, NJ). Levels of protein phosphorylation of the ErbB4 80-kDa cleavage fragment were quantitated with an IS-1000 digital imaging system (Alpha Innotech, San Leandro, CA).
For detection of ErbB4 expression levels in developing rat kidney, tissues were homogenized in ice-cold TGH buffer. Equal amounts of protein (100 g) were loaded and blotted with ErbB4 Ab-2 antibody. For immunoprecipitation, 2 mg protein was immunoprecipitated with ErbB4 c-18 antibody and blotted with ErbB4 Ab-2 antibody.
Collagen Gel Culture
MDCK tubulogenesis assays were performed in three-dimensional (3D) extracellular matrix gels as previously described (Cantley et al., 1994; Chen et al., 2004) . In brief, cells were suspended at 2 ϫ 10 3 cells/100 l in a neutralized collagen I solution that was composed of 1.5 mg/ml collagen I in DMEM/F12 containing 20 mM HEPES (pH 7.2) and were dispensed into 96-well plates and incubated at 37°C. After the collagen I solution had solidified, the complete culture medium with HGF, 20 ng/ml; HRG-␤1, 50 ng/ml; or HB-EGF, 50 ng/ml was added and renewed every day. One group of cells without growth factors served as control. Cysts and tubules were photographed after 9 -10 d of culture under phase contrast using a Nikon Diaphot TMD inverted microscope (Melville, NY).
Cell Proliferation
Cell proliferation was performed in 3D collagen I solution as previously described (Mai et al., 2005) . Briefly, 6 ϫ 10 4 cells embedded in 100 l collagen I solution were plated in 96-well plates as described in tubulogenesis and incubated in DMEM/F12 containing 5% fetal bovine serum (FBS) with or without (control) HRG-␤1, 50 ng/ml, or HB-EGF, 50 ng/ml, after pretreatment with the PI3K inhibitor LY294002 5 M or mitogen-activated protein kinase (MAPK) inhibitor U0126 5 M for 2 h. Medium was changed everyday with corresponding growth factors and inhibitors. After 72 h, cells were pulsed with [ 3 H]thymidine (1 Ci/well) for 24 h before collection. The gels were then removed from the plates and dialyzed against PBS for 24 h to remove free [ 3 H]thymidine. The cells in the gels were then lysed in 10% SDS, and 3 H radioactivity was measured in a scintillation counter.
Cell Adhesion
Microtiter plates (U-bottomed, 96-well) were coated with collagen I at the indicated concentrations in PBS for 1 h at 37°C. Plates were then washed with PBS and incubated with PBS containing 0.1% BSA for 60 min to block nonspecific adhesion. Cells (n ϭ 100,000) in 100 l serum-free DMEM were added in triplicate to 96-well plates and incubated for 1 h at 37°C, the time necessary for MDCK to adhere maximally to collagen I (data not shown). Nonadherent cells were removed by washing the wells with PBS. Cells were then fixed with 3.7% formaldehyde, stained with 1% crystal violet, and solubilized in 20% acetic acid, and the optical density (OD) of cell lysates was read at 570 nm. Cells bound to fetal calf serum were used as a positive control to indicate maximal cell adhesion, whereas cells bound to 1% BSA-coated wells were used as background. The percentage of cell adhesion was calculated as (OD of test Ϫ OD of the background)/(OD of the positive control Ϫ OD of the background).
Cell Motility Assay
Cell motility was measured by a transwell migration assay carried out in transwells consisting of PVDF-free polycarbonate filters with 8-m pores (Corning Costar, Acton, MA). The underside of each transwell was precoated with 10 g/ml collagen I overnight at 4°C, and the filter was subsequently blocked with 1% BSA for 1 h at 37°C to inhibit nonspecific migration. Cells, 5 ϫ 10 4 , in 100 l serum-free medium were added to the upper wells and were then allowed to migrate into the matrix coated on the underside of the 
a The sequence for the ErbB JM-c probe was designed according to our sequence results. b The GenBank number for the ErbB4 CYT-2 probe sequence is AY375307.
transwell for 4 h. Cells on the top of the filter were removed by wiping with a cotton swab, and the filter was then fixed in 3.7% formaldehyde in PBS. Migrating cells were stained with 1% crystal violet, and five random fields of view at 400ϫ magnification were counted and expressed as the average number of cells per field of view. Three independent experiments were performed and the data were represented as mean Ϯ SE.
Immunofluorescence Staining
Cells plated on glass coverslips were rinsed in PBSϩϩ (PBS plus 0.5 mM MgCl 2 and 0.9 mM CaCl 2 ) and fixed with 4% paraformaldehyde in PBSϩϩ for 30 min on ice. The fixed cells were permeabilized with 0.2% Triton X-100 in PBSϩϩ for 2 min at room temperature and washed three times with PBSϩϩ. After blocking with 5% normal goat serum and 1% BSA in PBSϩϩ, samples were incubated with primary antibodies overnight at 4°C in a moist chamber. Samples were then washed three times with PBSϩϩ, followed by incubation for 30 min with the respective conjugated second antibody (Jackson ImmunoResearch Laboratories, West Grove, PA). After three washes, cells were counterstained with TO-PRO-3 in PBS for 10 min and mounted with VectaShield mounting media (Vector Laboratories, Burlingame, CA). The images were examined using a Zeiss-410 confocal microscope (Thornwood, NY) at the Vanderbilt Imaging Core facility.
Statistics
Graphic data are presented as mean Ϯ SE. Student's t test was used for comparing different treatments and cell lines. Differences with p Ͻ 0.05 were considered statistically significant.
RESULTS
Expression and Localization of ErbB4 Isoforms in Rat Embryonic and Adult Kidney
The expression and localization of ErbB4 were examined in rat embryonic and adult kidneys. As shown in Figure 2A , ErbB4 expression was weakly detected by immunoblotting in rat metanephric kidney at E15 and was strongly expressed at E19. After birth, ErbB4 expression levels decreased. At postnatal day (P) 6 and in adult rats, ErbB4 protein expression was detected mainly in renal medulla. ErbB4 was immunolocalized to ureteric bud derivatives in E17.5 embryos ( Figure 2B ), similar to the localization previously reported for its ligands, HB-EGF and heregulin (Sakai et al., 1997; Takemura et al., 2002) . In adult kidney, ErbB4 was mainly expressed in the distal nephron and in epithelial cells of the cortical and medullary collecting duct (Figure 2, C and D) .
To investigate which ErbB4 isoforms were expressed during renal development, real-time PCR was performed using primers flanking the rat ErbB4 juxtamembrane domain or CYT-1 site and specific probes for each isoform. From E15 to adult, four ErbB4 isoforms were detected: JM-a, JM-c, CYT-1, and CYT-2, with JM-a being the main juxtamembrane isoform and CYT-2 the predominant cytoplasmic isoform (Figure 3, A and B) . At E19 the postnatal medulla exhibited the highest levels of expression of mRNA for JM-a and CYT-2, which corresponded to the ErbB4 protein expression level detected by immunoblotting. The identities of the amplified RT-PCR products were also confirmed by cloning the single ErbB4 JM or CYT RT-PCR products and sequencing the inserts.
ErbB4 Clone Selection and Phosphorylation Induced by HRG-␤1 and HB-EGF
In preliminary studies, we determined that commonly utilized cell lines derived from either adult collecting duct (IMCD cells) or ureteric bud (UB cells) failed to express detectable levels of endogenous ErbB4. Like IMCD and UB cells, MDCK II cells, another well-characterized polarized renal epithelial cell line, also does not express endogenous ErbB4. Furthermore, they do not spontaneously form tubules when grown in collagen gels in the presence of fetal calf serum, which allows us to determine the effects of specific growth factors on tubulogenesis. Therefore, we transfected full-length human ErbB4 cDNA isoforms into MDCK II cells, selected stably transfected cell lines, and . Quantitation of ErbB4 isoform mRNA level in rat development kidney by real-time PCR. ErbB4 JM isoforms (A) and CYT isoforms (B) were detected using specific primers and probes. Data were normalized to ubiquitin mRNA, which was used as internal control. Delta Ct was converted to arbitrary values by the formula 2 ϪdCt ϫ 10 3 . Results were expressed as mean Ϯ SE of three experiments.
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Vol. 18, November 2007confirmed ErbB4 expression levels by immunoblotting (Figure 4A ). In the ErbB4 JM-a isoform transfectants, a 180-kDa full-length ErbB4 band and a cleaved 80-kDa band were observed, indicating that both the JM-a/CYT-1 and JM-a/ CYT-2 isoforms could be cleaved in the normal growth medium. ErbB4 CYT-2 transfectants had bands of a smaller molecular weight than CYT-1 due to the 16-amino acid deletion (in both full-length and 80-kDa bands). The noncleavable ErbB4 JM-b isoform transfectants only expressed the full-length 180-kDa band ( Figure 4A) . In all the isoforms, especially in the JM-b/CYT-2 isoform, a band around 100 kDa was also detected. Whether this band represents ErbB4 degradation or belongs to the truncated form of ErbB4 has not yet been determined. The specificity of each transfected isoform was confirmed by RT-PCR ( Figure 4B ).
To demonstrate that the ErbB4 proteins expressed by the transfectants were functional, cells were stimulated with 50 ng/ml HRG-␤1 or 50 ng/ml HB-EGF for 10 min, and the phosphorylation level of ErbB4 was examined. As shown in Figure 4C , tyrosine phosphorylation of all ErbB4 isoforms increased in response to HRG-␤1 and HB-EGF stimulation, although the response to HB-EGF was less pronounced. Of interest, the JM-a/CYT-2 isoform uniquely demonstrated increased phosphorylation of the 80-kDa cytoplasmic cleavage fragment upon HB-EGF treatment (Figure 4, C and D) .
Expression of ErbB4 Isoforms Affects Tubulogenesis
When cultured in 3D collagen gels in the presence of fetal calf serum, MDCK II cells form cysts. Addition of HGF will induce tubule formation from single MDCK II cells or genetically homogenous epithelial cell clusters in collagen gels (Montesano et al., 1991; Santos and Nigam, 1993; Stuart et al., 1995; Balkovetz, 1998) . Unlike other cell lines derived from renal epithelium, wild-type MDCK II cells do not form tubules in response to ligand-mediated ErbB1 activation . In the presence of serum but the absence of HGF, all ErbB4 isoform-transfected cells exhibited a dramatic decrease in the size of cysts compared with vectortransfected cells (Figure 5 ). In the presence of HGF, vectortransfected MDCK II cells (control) exhibited the expected branching tubulogenesis ( Figure 5 ). All ErbB4 isoforms had decreased tubulogenesis in response to HGF administration compared with control cells. However, there were distinctly different patterns among the four isoforms. JM-a/CYT-1 cells developed into elongated tubules with minimal branching; JM-a/CYT-2 cells separated from each other and formed extensive, long cell protrusions, but no tubule formation was ever noted; JM-b/CYT-1 cells formed oblong tubule-like cysts; and JM-b/CYT-2 cells developed minimally branching tubules similar to JM-a/CYT-1 cells.
HRG-␤1 administration was unable to induce tubulogenesis in MDCK II cells. Instead, it induced cyst growth both in (ErbB1), it is likely that the HRG-␤1-induced cyst growth was mediated through ErbB3-mediated pathways. Of note, the HRG-␤1-mediated cysts from JM-a/CYT-1 cells demonstrated many small-spike or needle-shaped outgrowths, although no typical tubular formations were ever detected. EGF administration also failed to induce tubulogenesis in MDCK II cells expressing any of the four ErbB4 isoforms (data not shown). In contrast, in response to HB-EGF treatment, JM-a/CYT-2 cells formed tubules, whereas all the other transfected cells, including vector control cells, only formed cysts.
ErbB4 Expression Inhibits Cell Proliferation
Decreased cyst formation in 3D collagen gel culture ( Figure  5 ) suggested that ErbB4 overexpression might inhibit MDCK II cell proliferation. Cell proliferation was determined by measuring [
3 H]thymidine incorporation in the 3D collagen gel culture in DMEM/F-12 containing 5% FBS. After 4-d culture in 3D collagen gels, all four ErbB4 isoforms tested had significantly inhibited thymidine incorporation compared with vector-transfected cells ( Figure 6A ). JM-a/CYT-1 and JM-a/CYT-2 cells were further examined for their responses to HRG-␤1 or HB-EGF treatment. Because of the significant differences in the basal proliferation levels between vector and ErbB4 expressing cells (Figure 6A ), the effects of growth factors or inhibitors were examined using relative proliferation ratios corresponding to each cell type's basal growth rate. As shown in Figure 6B , compared with cells without growth factor addition, both HRG-␤1 and HB-EGF stimulated JM-a/CYT-1 and JM-a/CYT-2 cell proliferation (p Ͻ 0.05). Interestingly, the JM-a/CYT-2 cells had significantly increased thymidine incorporation in response to HB-EGF compared with HRG-␤1 (p Ͻ 0.05), whereas the opposite pattern was noted in JM-a/CYT-1 cells (p Ͻ 0.05). Both HRG-␤1-and HB-EGF-mediated cell proliferation were reduced by either a PI3K inhibitor (PY294002) or a MAPK inhibitor (U0126).
Expression of ErbB4 JM-a/CYT-2 Promotes MDCK Cells Attachment to Collagen I and Increases Cell Motility
We also investigated the effects of expression of ErbB4 isoforms on MDCK II cell adhesion to collagen I. As shown in Figure 7A , compared with vector alone or JM-a/CYT-1-and JM-b/CYT-1-transfected cells, both JM-a/CYT-2 and JM-b/ CYT-2 were much more adherent at concentrations of collagen I from 0.625 to 5 g/ml. Increased cell-matrix interactions may also affect cell chemotaxis and motility (Hotchkiss et al., 2005) . To investigate whether ErbB4 expression affected MDCK II cell motility, we used a transwell migration assay. MDCK II vector or ErbB4-expressing cells were placed in the upper chamber of transwell filters that had been coated on the underside with 5 g/ml collagen I solution and were allowed to migrate for 4 h. Compared with vector-transfected cells, ErbB4 JM-a/ CYT-2 expression significantly increased and JM-a/CYT-1 and JM-b/CYT-1 expression decreased cell motility ( Figure  7B ). The expression of the ErbB4 JM-b/CYT-2 isoform yielded results that were indistinguishable from controls.
HB-EGF Treatment Strongly Activated ERK1/2 Phosphorylation at Early Phases of Tubulogenesis in JM-a/CYT-2 Cells
Formation of branched tubular structures in epithelial cells induced by HGF requires distinct temporal responses (Medico et al., 1996; Sachs et al., 1996) . The first phase of the response (scattering), which results from cytoskeletal reorganization, loss of intercellular junctions, and cell migration, is dependent on PI3K and Rac activation (Ridley et al., 1995; Royal and Park, 1995) . The second phase (growth) requires stimulation of the Ras-MAPK cascade (Ponzetto et al., 1996; O'Brien et al., 2004) . The third phase (tubulogenesis) is dependent on the STAT (signal transducers and activators of transcription) pathway (Boccaccio et al., 1998) . HGF stimulates recruitment of STAT3 to the HGF receptor, tyrosine phosphorylation, nuclear translocation, and binding to the specific promoter element, Sis-inducible element (SIE). Therefore, we determined whether these pathways were altered in ErbB4-overexpressing MDCK II cells grown in collagen gels. We found that phospho-Akt levels were increased in both CYT-1 and -2, as well as vector alone transfected cells upon HRG-␤1 treatment, but not in response to HB-EGF treatment. Given that MDCK II cells also express ErbB3 receptors, which stimulates PI3K upon activation by HRG-␤1, we speculate that the observed HRG-␤1-stimulated Akt activation was mainly mediated by ErbB3 receptors. On the other hand, HRG-␤1 and HB-EGF demonstrated distinct patterns of ERK1/2 activation. Compared with JMa/CYT-1 cells, HB-EGF selectively induced ERK1/2 phosphorylation in JM-a/CYT-2 cells at early time points (30 min to 4 h), followed by deactivation at a later time point (20 h). All three cell lines expressed high basal levels of phospho-STAT3, which were not further stimulated by either HRG-␤1 or HB-EGF (Figure 8 ). Figure 8 . Effects of HRG-␤1 and HB-EGF on phosphorylation of Akt, ERK 1/2, and STAT3. Quiescent cells were trypsinized and plated into 3D collagen gel mixture at 60,000 cells per 100 l gel mixture with or without HRG-␤1 or HB-EGF (50 ng/ml) treatment. Cells were lysed at the indicated time point, and cell lysates were resolved by 10% SDS-PAGE and subjected to immunoblotting with anti-phospho-Akt antibody, anti-phospho-ERK 1/2 antibody, or antiphospho-STAT3 antibody. The membranes were then stripped and reprobed with anti-total ERK 1/2 antibody as a loading control. 
ErbB4 JM-a/CYT-2 Isoform Translocated to Cell Nucleus in Response to HB-EGF Stimulation
Although both JM-a/CYT-1 and JM-a/CYT-2 cells could be cleaved upon ligand stimulation, HB-EGF induced tubulogenesis only in JM-a/CYT-2 cells. Furthermore, HB-EGF was unable to induce tubulogenesis in either of the JM-b cells. These results suggested that although ErbB4 cleavage was involved in this process, JM-a/CYT-2 receptors mediated specific responses required for tubulogenesis. Recent studies indicated that ErbB4 JM-a/CYT-2 and JM-a/CYT-1 isoforms exhibit different nuclear localization in human breast cancer cells (Maatta et al., 2006) , suggesting a possible mechanism to explain the different responses of the JM-a isoforms. We therefore examined nuclear localization of the cytoplasmic tail of JM-a/CYT-1 and JM-a/CYT-2 in the transfected MDCK cells in response to stimulation with phorbol ester, PMA, which can induce proteolytic cleavage of ErbB4 JM-a isoforms (Vecchi et al., 1996) . ErbB4 expressing cells incubated with or without 100 ng/ml PMA for 1 h at 37°C were tested for ErbB4 cleavage by Western blot and ErbB4 localization by immunofluorescence staining. As expected, PMA treatment increased expression of the 80-kDa fragment of both isoforms ( Figure 9A ). All four ErbB4 isoforms were primarily located at the plasma membrane and in the cytosol in the absence of PMA treatment. After PMA treatment, the JM-a/CYT-2 isoform selectively translocated to the nucleus, whereas in JM-a/CYT-1 cells, ErbB4 immunoreactivity was detected in the cytosol and perinuclear regions. As expected, PMA did not significantly alter localization of either JM-b/CYT-1 or JM-b/CYT-2 ( Figure 9B ). Of interest, HB-EGF also selectively induced nuclear translocation of the JM-a/ CYT-2 isoform, whereas HRG-␤1 failed to induce nuclear translocation of either JM-a isoform ( Figure 9C ).
DISCUSSION
ErbB4 is highly expressed in developing ductal epithelium, especially the terminal ducts and end buds in breast, where it has been suggested to play a role in regulating terminal differentiation of the mammary gland (Schroeder and Lee, 1998; Srinivasan et al., 1998; Jones et al., 1999) . The metanephric kidney, which is also primarily comprised of branching ductal epithelial structures, requires soluble factors, including members of the EGF family, for normal development. Our previous studies showed that HB-EGF protein was expressed in the ureteric bud of embryonic kidneys. HB-EGF also induces branching tubulogenesis in cultured mouse UB cells (Takemura et al., 2001) . In addition to HB-EGF, we have determined that HRG-␤1 is also expressed in the ureteric buds. Both HB-EGF and HRG-␤1 can signal through activation of ErbB4. Thus the localization of ErbB4 and its ligands at ureteric bud suggests that ErbB4 may play a role in renal tubule development.
Consistent with previous reports (Kainulainen et al., 2000) , we found that the main ErbB4 isoforms in rat kidney were JM-a and CYT-2. Another noncleavable isoform, JM-c, which does not contain either JM-a or JM-b sequence, was also detected after E19, but in relatively lower amounts when compared with the JM-a isoform. On the other hand, the CYT-1 isoform was detected in early renal development stage from E15 to P6. These results suggest that during nephric development, different ErbB4 isoforms may be involved in nephrogenic processes and may act in coordination with each other.
The organization of polarized epithelia into architecturally distinct tubules is a characteristic feature of the mammalian kidney and is central to its physiological functions (Dressler, 2002) . In this regard, we have utilized a welldescribed system of growth of MDCK II cells in collagen gels to recapitulate the events of branching morphogenesis. We demonstrated that in MDCK II cells, ErbB4 isoforms manifested 1) impaired cyst formation; 2) different defects in tubulogenesis upon HGF treatment, with JM-a/CYT-1 and JM-b/CYT-2 cells demonstrating elongated tubules without branching, JM-a/CYT-2 cells exhibiting scattered cells with extensive cell protrusions, and JM-b/CYT-1 cells producing coil-coiled tubule-like cysts; 3) responses to HRG-␤1 treatment by rescuing cyst growth; and 4) ErbB4 JM-a/CYT-2 isoform, which lacks the PI3K-binding domain, induced branching tubule formation upon HB-EGF administration.
Tubulogenesis involves the coordination of a number of cellular functions, including cell proliferation, adhesion, migration, and apoptosis. Consistent with a role for ErbB4 in Figure 9 . Cleavage and nuclear translocation of ErbB4 isoforms. (A) ErbB4 cleavage after PMA treatment. Cells were treated with 100 ng/ml PMA for 1 h. After SDS-PAGE and transfer to PVDF membrane, the samples were immunoblotted with anti-ErbB-4. (B and C) ErbB4 subcellular localization in response to PMA, HRG-␤1, or HB-EGF treatment. ErbB4 isoformtransfected MDCK II cells were grown on coverslips, and cells were incubated with 10 ng/ml leptomycin B (LMB) for 12 h, an inhibitor of nuclear export, before treated with or without (as control) PMA (B) or HRG-␤1 or HB-EGF (C) for 1 h. Subcellular localization of an intracellular ErbB4 epitope was determined by confocal microscopy. Green, ErbB4 staining; red, nuclei stained with TO-PRO-3.
inhibiting proliferation and/or inducing differentiation in other cell types (Srinivasan et al., 2000; Ni et al., 2001; Sartor et al., 2001) , we determined that ErbB4 isoform expression significantly inhibited MDCK II cell proliferation in 3D collagen gel culture ( Figure 6A ), which may be the underlying reason for the poor cyst formation in the control group. HRG-␤1 did stimulate proliferation in the ErbB4-overexpressing cells, as was indicated by the cyst formation and cell proliferation assays, but could not promote MDCK II tubulogenesis. Consistent with previous studies , EGF was also unable to induce tubulogenesis in MDCK II cells with overexpression of vector alone or any of the ErbB4 isoforms. In contrast, in response to HB-EGF, only the JM-a/CYT-2 ErbB4 cells formed tubules, whereas vectortransfected cells and the other ErbB4 isoforms only formed cysts. Because HB-EGF can bind to both EGFR and ErbB4, the tubule formation seen in response to HB-EGF treatment in JM-a/CYT-2 cells suggested that a balance between activation of both EGFR and ErbB4 might be required for tubulogenesis. However, because this response was not seen with the other ErbB4 isoforms, it further suggested that the cleaved JM-a/CYT-2 intracellular domain (ICD-JM-a/CYT-2) may play a role, because HB-EGF selectively led to an increase in the cleaved phosphorylated cytoplasmic fragment of JM-a/CYT-2 ( Figure 4C ).
The different responses of JM-a/CYT-2 and JM-b/CYT-2 isoforms to HB-EGF suggested that the JM-a/CYT-2-mediated tubule formation was related to ErbB4 cleavage, which is the only difference between those two isoforms. On the other hand, even though both ErbB4 JM-a/CYT-1 and JMa/CYT-2 isoforms are cleaved after activation, no branching tubule formation was detected in response to HB-EGF treatment in JM-a/CYT-1 cells. As previously noted, ICD-JM-a/ CYT-1 contains a PI3K-binding domain and a WW-binding motif that are absent in ICD-JM-a/CYT-2. Compared with HRG-␤1, we detected less phospho-Akt activation upon HB-EGF treatment in both JM-a/CYT-1 and JM-a/CYT-2, suggesting that differential PI3K binding and/or activation of PI3K/Akt pathway were not involved in the tubule formation in this situation. On the other hand, HB-EGF stimulated ERK phosphorylation to a much greater extent in JM-a/ CYT-2 cells compared with either JM-a/CYT-1-or vectortransfected cells. Strong MAPK activation at early time points may facilitate MDCK epithelial-mesenchymal transition, an important step in tubulogenesis (O'Brien et al., 2002) .
Several studies have reported that WW-binding motifs in ErbB4 ICD may mediate subcellular localization of the cytoplasmic tail (Komuro et al., 2003; Omerovic et al., 2004) . CYT-1 isoform cytoplasmic tails are more likely to be ubiquitinated and degraded in the proteosome, whereas CYT-2 isoform cytoplasmic tails are less likely to be degraded and can translocate to the nucleus (Maatta et al., 2006) . In agreement with these studies, we found that when the different ErbB4 isoforms were treated with PMA to induce cleavage of the JM-a isoforms, only JM-a/CYT-2 was translocated to the nucleus. Furthermore, the two ErbB4 ligands differentially affected nuclear translocation. HB-EGF, which induced tubulogenesis, selectively induced nuclear translocation of the JM-a/CYT-2 isoform of ErbB4, whereas there was no nuclear translocation in response to HRG-␤1 treatment. At present, we do not understand this failure of HRG-␤1 to induce nuclear localization but speculate it may be due to different intracellular signaling in response to simultaneous activation of ErbB3 (HRG-␤1) versus ErbB1 (HB-EGF).
Initiation of multiple downstream signaling cascades in response to ligand-dependent formation of homo-or heterodimeric ErbB receptor complex formation has been well described. Recently, an alternative direct signaling mechanism has been proposed for ErbB4 (Ni et al., 2001; Lee et al., 2002) . After TACE-dependent cleavage of the ErbB4 extracellular domain, regulated intracellular proteolysis produces a soluble ICD of ErbB4, which can be translocated to the nucleus and may possess transcriptional activity (Ni et al., 2001; Lee et al., 2002; Komuro et al., 2003; Williams et al., 2004) . In other cell types, ErbB4 has been shown to facilitate nuclear translocation of other transcription factors, including STAT5a, YAP65 (Omerovic et al., 2004; Muraoka-Cook et al., 2006) , and TAB2 and N-Cor (Sardi et al., 2006) . Therefore, we propose that the increased nuclear translocation of JMa/CYT-2 cells may serve to mediate complex cellular responses, such as increased cell-matrix adhesion, cell motility, and cell proliferation, to modulate MDCK II tubulogenesis. Further studies will be required to determine which transcriptional factors are involved in the observed HB-EGFinduced tubulogenesis.
In conclusion, we report that ErbB4 was mainly expressed in ureteric buds and their derivatives. Low levels of ErbB4 in adult kidney were detected primarily in collecting ducts. In the rat kidney, JM-a was the major ErbB4 juxtamembrane isoform and CYT-2 was the major cytoplasmic tail isoform. In MDCK II cells transfected with ErbB4 isoforms, we demonstrated that the ErbB4 JM-a/CYT-2 isoform, which is a cleavable isoforms that lacks the PI3K-and WW-domainbinding sites, exhibits rapid attachment, increased motility, and HB-EGF-induced tubulogenesis, suggesting it may play a role in renal tubule development.
